These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2695823)

  • 41. [Treatment of blepharospasm by injections of botulinum toxin].
    Adenis JP; Lebraud P; Franco JL
    Bull Soc Ophtalmol Fr; 1987; 87(6-7):761-2, 767. PubMed ID: 3664886
    [No Abstract]   [Full Text] [Related]  

  • 42. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin treatment of blepharospasm.
    Elston JS
    Adv Neurol; 1988; 50():579-81. PubMed ID: 3400511
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical use of botulinum toxin. National Institutes of Health Consensus Development Conference Statement, November 12-14, 1990.
    Arch Neurol; 1991 Dec; 48(12):1294-8. PubMed ID: 1845036
    [No Abstract]   [Full Text] [Related]  

  • 45. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum toxin therapy for strabismus and blepharospasm: Bascom Palmer Eye Institute experience.
    Flynn JT; Bachynski B
    Trans New Orleans Acad Ophthalmol; 1986; 34():73-88. PubMed ID: 3726970
    [No Abstract]   [Full Text] [Related]  

  • 47. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations.
    Kraft SP; Lang AE
    Can J Neurol Sci; 1988 Aug; 15(3):276-80. PubMed ID: 3208210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.
    Girlanda P; Vita G; Nicolosi C; Milone S; Messina C
    J Neurol Neurosurg Psychiatry; 1992 Sep; 55(9):844-5. PubMed ID: 1328540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study.
    Taylor JD; Kraft SP; Kazdan MS; Flanders M; Cadera W; Orton RB
    Can J Ophthalmol; 1991 Apr; 26(3):133-8. PubMed ID: 2054723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum toxin for the treatment of essential blepharospasm.
    Shore JW; Leone CR; O'Connor PS; Neuhaus RW; Arnold AC
    Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic uses of botulinum toxin (Botox).
    Epperson LW
    Ala Med; 1995 Nov-1996 Jan; 65(5-7):49-50. PubMed ID: 8607384
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of botulinum toxin in ophthalmology].
    Huber A; Meyer M
    Klin Monbl Augenheilkd; 1986 Feb; 188(2):89-94. PubMed ID: 3713087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of botulinum toxin.
    Hayes DM
    West J Med; 1987 Jan; 146(1):99. PubMed ID: 3825115
    [No Abstract]   [Full Text] [Related]  

  • 54. Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy.
    Jankovic J
    Adv Neurol; 1988; 50():583-91. PubMed ID: 3041763
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Essential blepharospasm and botulinum toxin. An electrophysiologic study].
    Laskawi R; Damenz W; Roggenkämper P; Schröder M; Brauneis J
    HNO; 1990 Jan; 38(1):29-32. PubMed ID: 2312364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm.
    Wirtschafter JD
    Ophthalmology; 1991 Mar; 98(3):357-66. PubMed ID: 2023757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum A toxin therapy in ophthalmology: a report of patients with facial dystonias.
    Vissenberg I; Dieleman-Smet H; Tassignon MJ
    Bull Soc Belge Ophtalmol; 1993; 248():77-82. PubMed ID: 8044337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
    Singer M
    Ophthalmology; 1996 Mar; 103(3):348. PubMed ID: 8600402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.